Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Pain and Parkinson's disease: Current mechanism and management updates

Viseux FJF, Delval A, Simoneau M, Defebvre L.

Eur J Pain. 2023 May;27(5):553-567. doi: 10.1002/ejp.2096. Epub 2023 Mar 3.

Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer's Disease and Parkinson's Disease

Yang J, Zhang W, Zhang S, Iyaswamy A, Sun J, Wang J, Yang C.

Aging Dis. 2023 Jun 1;14(3):652-669. doi: 10.14336/AD.2022.0927.

Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases

Plascencia-Villa G, Perry G.

Int J Mol Sci. 2023 Aug 6;24(15):12486. doi: 10.3390/ijms241512486.

L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin

Riederer P, Horowski R.

J Neural Transm (Vienna). 2023 Nov;130(11):1323-1335. doi: 10.1007/s00702-023-02692-9. Epub 2023 Oct 5.

The importance of social behavior in nonhuman primate studies of aging: A mini-review

Rothwell ES, Carp SB, Bliss-Moreau E.

Neurosci Biobehav Rev. 2023 Nov;154:105422. doi: 10.1016/j.neubiorev.2023.105422. Epub 2023 Oct 6.

Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint

Faysal M, Khan J, Zehravi M, Nath N, Singh LP, Kakkar S, Perusomula R, Khan PA, Nainu F, Asiri M, Khan SL, Das R, Emran TB, Wilairatana P.

Chin Med. 2023 Nov 24;18(1):154. doi: 10.1186/s13020-023-00846-1.

Cytokine activity in Parkinson's disease

Dzamko N.

Neuronal Signal. 2023 Dec 4;7(4):NS20220063. doi: 10.1042/NS20220063. eCollection 2023 Dec.

Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases

Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W, Yoon KS, Kim SS, Yeo EJ, Kang I.

Int J Mol Sci. 2023 Dec 21;25(1):124. doi: 10.3390/ijms25010124.

Ameliorative effects of Portulaca oleracea L. (purslane) and its active constituents on nervous system disorders: A review

Jalali J, Ghasemzadeh Rahbardar M.

Iran J Basic Med Sci. 2023 Jan;26(1):2-12. doi: 10.22038/IJBMS.2022.65764.14464.

The role of exercise in Parkinson's Disease

Almikhlafi MA.

Neurosciences (Riyadh). 2023 Jan;28(1):4-12. doi: 10.17712/nsj.2023.1.20220105.

Effects of COVID-19 on Synaptic and Neuronal Degeneration

Alqahtani MS, Abbas M, Alshahrani MY, Alabdullh K, Alqarni A, Alqahtani FF, Jambi LK, Alkhayat A.

Brain Sci. 2023 Jan 12;13(1):131. doi: 10.3390/brainsci13010131.

The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease

Tang X, Xing S, Ma M, Xu Z, Guan Q, Chen Y, Feng F, Liu W, Chen T, Chen Y, Sun H.

J Med Chem. 2023 Feb 23;66(4):2282-2307. doi: 10.1021/acs.jmedchem.2c01552. Epub 2023 Feb 9.

Transcranial low-intensity ultrasound stimulation for treating central nervous system disorders: A promising therapeutic application

Hu YY, Yang G, Liang XS, Ding XS, Xu DE, Li Z, Ma QH, Chen R, Sun YY.

Front Neurol. 2023 Mar 8;14:1117188. doi: 10.3389/fneur.2023.1117188. eCollection 2023.

LRRK2 Structure-Based Activation Mechanism and Pathogenesis

Zhang X, Kortholt A.

Biomolecules. 2023 Mar 28;13(4):612. doi: 10.3390/biom13040612.

Role of Non-Receptor-Type Tyrosine Phosphatases in Brain-Related Diseases

He Y, Nan D, Wang H.

Mol Neurobiol. 2023 Nov;60(11):6530-6541. doi: 10.1007/s12035-023-03487-5. Epub 2023 Jul 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias